4-Hydroxyamphetamine
| Clinical data | |
|---|---|
| Trade names | Paredrine, Paremyd, Pedrolon, Mycadrine, Paredrinex, others |
| Other names | 4-Hydroxyamphetamine; 4-HA; Hydroxyamfetamine; Oxamphetamine; Norpholedrine; para-Hydroxyamphetamine; PHA; α-Methyltyramine; Methyltyramine, Hydroxyamphetamine (USAN US) |
| Routes of administration | Eye drops |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.002.866 |
| Chemical and physical data | |
| Formula | C9H13NO |
| Molar mass | 151.209 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Hydroxyamphetamine, also known as 4-hydroxyamphetamine or norpholedrine and sold under the brand names Paredrine and Paremyd among others, is a sympathomimetic medication used in eye drops to dilate the pupil for eye examinations.[1][2][3][4]
Hydroxyamfetamine acts as a norepinephrine releasing agent and hence is an indirectly acting sympathomimetic.[5][6] It is a substituted phenethylamine and amphetamine.[4]
Hydroxyamphetamine appeared to remain marketed only in the Czech Republic as of 2004.[3]
- ^ Cite error: The named reference
Elks2014was invoked but never defined (see the help page). - ^ Cite error: The named reference
MortonHall2012was invoked but never defined (see the help page). - ^ a b Cite error: The named reference
IndexNominum2004was invoked but never defined (see the help page). - ^ a b Cite error: The named reference
DrugBankwas invoked but never defined (see the help page). - ^ Cite error: The named reference
Lepore1985was invoked but never defined (see the help page). - ^ Cite error: The named reference
Cho1978was invoked but never defined (see the help page).